Testosterone Replacement Therapy (TRT)
- 2014: Hormones and cardiovascular disease in older men.
- 2014: An update on male hypogonadism therapy.
- 2014: Testosterone deficiency: a historical perspective.
- 2014: Influence of aromatase inhibition on the bone-protective effects of testosterone.
- 2013: Exogenous testosterone: a preventable cause of male infertility
- 2013: Testosterone administration modulates moral judgments depending on second-to-fourth digit ratio.
- 2012: The importance of testosterone in the treatment of metabolic syndrome in men.
- 2011: Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men.
- 2009: Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration.
- 2009: Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men.
- 2007: The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.
- 2006: Testosterone administration reduces empathetic behavior: a facial mimicry study.
- 2005: Inhibition of 5a-reductase blocks prostate effects of testosterone without blocking anabolic effects
- 2004: Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5a-reduced metabolites in the hippocampus.
- 2004: The Rationale, Efficacy and Safety of Androgen Therapy in Older Men: Future Research and Current Practice Recommendations.
- 2004: Intramuscular Testosterone Undecanoate: Pharmacokinetic Aspects of a Novel Testosterone Formulation during Long-Term Treatment of Men with Hypogonadism
- 2003: Differential anabolic effects of testosterone and amino acid feeding in older men.
- 2003: Effects of an oral androgen on muscle and metabolism in older, community-dwelling men.
- 2001: Testosterone dose-response relationships in healthy young men
- 2001: Hypogonadism and androgen replacement therapy in elderly men.
- 1975: Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate.
Steroids
- 2016: The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
- 2016: Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome.
- 2016: Sex Steroids and Major Psychoses: Which Role for DHEA-S and Progesterone.
- 2015: Effects of anabolic-androgens on brain reward function.
- 2015: Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.
- 2014: Anabolic androgenic steroids reverse the beneficial effect of exercise on tendon biomechanics: an experimental study.
- 2013: A cellular memory mechanism aids overload hypertrophy in muscle long after an episodic exposure to anabolic steroids.
- 2013: Detection of designer steroid methylstenbolone in "nutritional supplement" using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites.
- 2013: Cardiometabolic risks during anabolic hormone supplementation in older men.
- 2012: Cognitive deficits in long-term anabolic-androgenic steroid users.
- 2012: National Athletic Trainers' Association Position Statement: Anabolic-Androgenic Steroids
- 2012: Anabolic steroids in patients undergoing total knee arthroplasty.
- 2011: The use of anabolic steroids as a strategy in reversing denervation atrophy after delayed nerve repair
- 2010: Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction.
- 2010: Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
- 2008: Pharmacology of anabolic steroids.
- 2007: Testosterone reduces conscious detection of signals serving social correction: implications for antisocial behavior.
- 2006: Androgenic-anabolic steroids associated with mechanical loading inhibit matrix metallopeptidase activity and affect the remodeling of the achilles tendon in rats.
- 2006: Medical Issues Associated with Anabolic Steroid Use: Are They Exaggerated?
- 2001: Treatment strategies of withdrawal from long-term use of anabolic-androgenic steroids.
- 2001: Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males.
- 2001: Anabolic steroids increase exercise tolerance.
- 2000: The effect of supraphysiological doses of anabolic androgenic steroids on collagen metabolism.
- 2000: Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite.
- 2000: The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program.
- 1999: Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging
- 1999: Effects of dehydroepiandrosterone vs androstenedione supplementation in men.
- 1999: The effect of anabolic steroids and corticosteroids on healing of muscle contusion injury.
- 1998: Ultrastructural analysis of ruptured tendon from anabolic steroid users.
- 1997: Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government
- 1985: Effect of androgenic-anabolic steroids and heavy strength training on patellar tendon morphological and mechanical properties.
Growth Hormone
- 2009: Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study.
- 1999: Growth hormone and body composition in athletes.
SARMS
- 2015: Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
- 2015: Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
- 2014: Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
- 2014: Selective androgen receptor modulators for the treatment of late onset male hypogonadism
- 2013: Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
- 2013: A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate.
- 2013: Computer-aided (in silico) approaches in the mode-of-action analysis and safety assessment of ostarine and 4-methylamphetamine.
- 2013: The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men
- 2011: Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
- 2011: SARM-S4 and metabolites detection in sports drug testing: a case report.
- 2009: Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.
- 2006: Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery.
Ibuprofen
- 2017: High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults.
- 2011: Rhabdomyolysis/myoglobinemia and NSAID during 48 h ultra-endurance exercise (adventure racing).
- 2008: The effects of ibuprofen on muscle hypertrophy, strength, and soreness during resistance training.
- 2003: The effects of ibuprofen on delayed muscle soreness and muscular performance after eccentric exercise.
- 2003: Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis.
Other
- 2017: Intended or Unintended Doping? A Review of the Presence of Doping Substances in Dietary Supplements Used in Sports.
- 2014: Identification of black market products and potential doping agents in Germany 2010-2013.
- 2014: Exercise and Sport Performance with Low Doses of Caffeine
- 2013: The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance
- 2013: Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
- 2013: Strength training induces muscle hypertrophy and functional gains in black prostate cancer patients despite androgen deprivation therapy.
- 2012: Effects of eight-week supplementation of Ashwagandha on cardiorespiratory endurance in elite Indian cyclists
- 2011: An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda
- 2011: Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet.
- 2011: Performance-Enhancing Drugs in Sports: How Chemists Catch Users (PDF)
- 2010: Caffeinated chewing gum increases repeated sprint performance and augments increases in testosterone in competitive cyclists.
- 2010: The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis
- 2010: Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009.
- 2008: L-Theanine and Caffeine in Combination Affect Human Cognition as Evidenced by Oscillatory alpha-Band Activity and Attention Task Performance
- 2008: Temporal strength changes from resistance exercise and albuterol on unloaded muscle.
- 2004: Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids - results of an international study.
- 2004: Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
- 2003: Effects of acute prolactin manipulation on sexual drive and function in males.
- 2002: Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
- 1980: Tamoxifen suppresses gonadotropin-induced 17 alpha-hydroxyprogesterone accumulation in normal men.
